Pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Mercury Laboratories has informed that Jagdish Patil has been appointed as Head of the Department (Dept.-Injectable Production) of the Company with effect from June 14, 2024. The details of changes as required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with Section V-A of Chapter V of Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
